SS Innovations International, Inc. (NASDAQ: SSII), a developer of surgical robotic technologies, announced the appointment of Sarah M. Romano as chief financial officer, effective Aug. 3, 2026. Romano, who is based in the United States, brings more than two decades of finance leadership experience in the medical technology and life sciences sectors. She will help lead the company’s financial operations as it advances its global expansion strategy, including pursuit of U.S. FDA approval for its SSi Mantra surgical robotic system.
Most recently, Romano served as chief financial officer of Vicarious Surgical, where she led financial and operational initiatives to reduce cash burn, strengthen the balance sheet and support strategic objectives. She previously held CFO roles at Entero Therapeutics and Kiora Pharmaceuticals, raising more than $100 million through public and private financings while overseeing strategic transactions, SEC reporting and investor relations. Her extensive background in financial management and capital markets is expected to be instrumental as SS Innovations scales its operations and seeks regulatory approvals.
The appointment comes at a critical time for SS Innovations, which develops innovative surgical robotic technologies with a vision to make the benefits of robotic surgery affordable and accessible to a larger segment of the global population. The company’s product range includes its proprietary SSi Mantra surgical robotic system and its comprehensive suite of SSi Mudra surgical instruments, which support a variety of surgical robotic procedures including cardiac surgery. An American company headquartered in India, SS Innovations plans to expand the global presence of its technologically advanced, user-friendly, and cost-effective surgical robotic solutions.
Romano’s experience in the medical technology sector aligns with SS Innovations’ strategic priorities. Her track record of raising capital and managing financial operations in growth-stage companies is expected to support the company’s efforts to secure FDA clearance and expand into new markets. The company’s focus on affordability and accessibility positions it to compete with established players in the surgical robotics space, which is dominated by high-cost systems.
The full press release can be accessed at https://ibn.fm/pAqlP. For the latest news and updates relating to SSII, visit the company’s newsroom at https://ibn.fm/SSII.
This executive appointment underscores SS Innovations’ commitment to strengthening its leadership team as it prepares for the next phase of growth. With Romano at the helm of financial operations, the company is poised to navigate the complexities of regulatory approval and commercial expansion, aiming to bring robotic surgery to a broader global audience.
